MiR-150 predicts survival in patients with sepsis and inhibits LPS-induced inflammatory factors and apoptosis by targeting NF-κB1 in human umbilical vein endothelial cells
- 26 April 2018
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 500 (3), 828-837
- https://doi.org/10.1016/j.bbrc.2018.04.168
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- An unbiased silencing screen in muscle cells identifies miR-320a, miR-150, miR-196b, and miR-34c as regulators of skeletal muscle mitochondrial metabolismMolecular Metabolism, 2017
- An NF-κB-microRNA regulatory network tunes macrophage inflammatory responsesNature Communications, 2017
- Crocodylian nuclear factor kappa BComparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 2017
- MiR‐150 alleviates neuropathic pain via inhibiting toll‐like receptor 5Journal of Cellular Biochemistry, 2017
- miR-150 regulates obesity-associated insulin resistance by controlling B cell functionsScientific Reports, 2016
- MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathwayImmunology Letters, 2015
- MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseasesAutoimmunity, 2015
- Expression Profile of MicroRNAs in Gram-Negative Bacterial SepsisShock, 2015
- Elevated miR‐122 serum levels are an independent marker of liver injury in inflammatory diseasesLiver International, 2014
- TLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathwayJournal of Pineal Research, 2010